Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fed Conditions.
CFA-1048-1-25
Phase 1 other active
Quick answer
Bioequivalence of Mirabegron 50 mg Prolonged-Release Tablets in Healthy Participants Under Fed Conditions. for No medical condition. is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratorios Tillomed Spain S.L.U
- Indication
- No medical condition.
- Phase
- Phase 1
- Modality
- other
- Status
- active